BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹42.02 | ₹36.10 | ₹30.43 | ₹24.60 | ₹11.61 |
What is the latest Earnings Per Share (EPS) of BETA DRUGS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹42.02 |
| Mar2024 | ₹36.10 |
| Mar2023 | ₹30.43 |
| Mar2022 | ₹24.60 |
| Mar2021 | ₹11.61 |
How is Earnings Per Share (EPS) of BETA DRUGS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹42.02 | 16.40 | |
| Mar2024 | ₹36.10 | 18.63 | |
| Mar2023 | ₹30.43 | 23.70 | |
| Mar2022 | ₹24.60 | 111.89 | |
| Mar2021 | ₹11.61 | - | |
Compare Earnings Per Share (EPS) of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,281.3 Cr | -3% | -14.3% | 14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -3% |
-14.3% |
14.1% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses